Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0942820080070010033
Journal of Korean Brain Tumor Society
2008 Volume.7 No. 1 p.33 ~ p.37
Clinical Analysis of Hemangioblastoma
Lee Seung-Hwan

Park Bong-Jin
Kim Tae-Sung
Lim Young-Jin
Abstract
Objective: To find the most important factors of the clinical outcomes of the intracranial hemangioblastomas, we analyzed all the patients admitted to our hospital from 1986 to 2005 with hemangioblastoma.

Methods: This study included all the patients with histologically verified hemangioblastoma in our hospital over a period of 20 years. The medical, radiological, surgical records from these patients were reviewed retrospectively.

Results: There was a total 37 patients(16 males and 21 females). 32 patients(86.5%) harbored sporadic hemangioblastoma. 5 patients(13.5%) had von Hippel-Lindau syndrome. 30 out of 37 patients underwent total removal surgery were more likey to have good tumor control than 7 patients whose tumor were subtotally or partially removed required adjuvant therapy. Among subtotally removed patients, 4 patients were treated with radiosurgery and 3 patients with conventional radiotheraphy. Three of subtotally removed patients underwent 2nd surgery for recurred tumor, and 1 patient expired due to radiation induced glioblastoma multiforme.

Conclusion: In the treatment for intracranial hemangioblastoma, surgically total removal was treatment of choice. If tumor was subtotally removed, radiosurgery for remnant tumor will be adequate for adjuvant therapy.
KEYWORD
Hemangioblastoma, von Hippel-Lindau disease
FullTexts / Linksout information
Listed journal information
´ëÇÑÀÇÇÐȸ ȸ¿ø